Shanghai Jinhe Bio-technology Co., Ltd.is a high Bio-Tech private enterprise dedicated to developing, manufacturing and marketing Anti-Cancer APIs and their intermediates. Jinhe was established in March 2002. Based on the R&D achievement of FUDAN university, at the beginning it launched the international business of processing Paclitaxel API. After several years of development, we become the largest processor on Taxus biomass in China. Furthermore, we successfully developed Docetaxel Anhydrous(...